Viral Threats Research
Abstract
This effort designs and tests new vaccine candidates in the laboratory against hemorrhagic fever viruses (i.e., dengue virus, Hantaviruses, Lassa fever virus and Crimean-Congo hemorrhagic fever virus) and assesses other non-vaccine technologies to protect against hemorrhagic fever viruses. Efforts also include establishing and maintaining of clinical trial sites worldwide.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2021
- Source ID
- 866489d36c650648c05b572d6a1db88d
Related Documents
- Root: Medical Technology